SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001437749-16-043116
Filing Date
2016-12-08
Accepted
2016-12-08 16:39:05
Documents
4
Period of Report
2017-01-06
Effectiveness Date
2016-12-08

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A dffn20161206_def14a.htm DEF 14A 635627
2 a2.jpg GRAPHIC 108694
3 a1.jpg GRAPHIC 253911
4 ex99-1img001.jpg GRAPHIC 4079
  Complete submission text file 0001437749-16-043116.txt   1142156
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37942 | Film No.: 162041853
SIC: 2834 Pharmaceutical Preparations